Literature DB >> 20696481

Not as golden as standards should be: interpretation of the Hamilton Rating Scale for Depression.

Levente Kriston1, Alessa von Wolff.   

Abstract

BACKGROUND: The Hamilton Rating Scale for Depression (HRSD) is one of the most frequently used instruments in antidepressant trials.
METHODS: We examined different recommendations for classification of subjects according to depression severity by the HRSD.
RESULTS: Several differences between recommendations were identified leading to the conclusion that a consensus on interpretation is largely missing. LIMITATIONS: Brief narrative review.
CONCLUSIONS: Widely accepted standards for the interpretation of scores on the HRSD are needed.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20696481     DOI: 10.1016/j.jad.2010.07.011

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  13 in total

1.  The lack of impact of quality-of-life measures in schizophrenia: a shared responsibility?

Authors:  Laurent Boyer; Pascal Auquier
Journal:  Pharmacoeconomics       Date:  2012-06-01       Impact factor: 4.981

2.  Transcultural Adaptation of GRID Hamilton Rating Scale For Depression (GRID-HAMD) to Brazilian Portuguese and Evaluation of the Impact of Training Upon Inter-Rater Reliability.

Authors:  Ricardo Henrique-Araújo; Flávia L Osório; Mônica Gonçalves Ribeiro; Ivandro Soares Monteiro; Janet B W Williams; Amir Kalali; José Alexandre Crippa; Irismar Reis De Oliveira
Journal:  Innov Clin Neurosci       Date:  2014-07

3.  Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.

Authors:  William V Bobo; Gabriela C Angleró; Gregory Jenkins; Daniel K Hall-Flavin; Richard Weinshilboum; Joanna M Biernacka
Journal:  Hum Psychopharmacol       Date:  2016-03-21       Impact factor: 1.672

4.  Metacognitive Training for Obsessive-Compulsive Disorder: a study protocol for a randomized controlled trial.

Authors:  Franziska Miegel; Cüneyt Demiralay; Steffen Moritz; Janina Wirtz; Birgit Hottenrott; Lena Jelinek
Journal:  BMC Psychiatry       Date:  2020-07-06       Impact factor: 3.630

5.  SIGMA-VB: Validity and reliability of the Brazilian Portuguese version of the Montgomery-Åsberg Depression Rating Scale using the Structured Interview Guide for the MADRS.

Authors:  Fernando Fernandes; Adriana Carneiro; Rodolfo N Campos; Marcio G Soeiro-de-Souza; Vivian B Barros; Ricardo A Moreno
Journal:  Braz J Psychiatry       Date:  2019-02-18       Impact factor: 2.697

6.  Do side effects of antidepressants impact efficacy estimates based on the Hamilton Depression Rating Scale? A pooled patient-level analysis.

Authors:  Fredrik Hieronymus; Alexander Lisinski; Elias Eriksson; Søren Dinesen Østergaard
Journal:  Transl Psychiatry       Date:  2021-04-27       Impact factor: 6.222

7.  Dynamic changes of intestinal flora in patients with irritable bowel syndrome combined with anxiety and depression after oral administration of enterobacteria capsules.

Authors:  Qingqing Guo; Hao Lin; Pengcheng Chen; Songlin Tan; Zhiyong Wen; Lijian Lin; Jianquan He; Jianbo Wen; Shiyun Lu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  Assessment of depression in medical patients: a systematic review of the utility of the Beck Depression Inventory-II.

Authors:  Yuan-Pang Wang; Clarice Gorenstein
Journal:  Clinics (Sao Paulo)       Date:  2013-09       Impact factor: 2.365

9.  Validating a functional near-infrared spectroscopy diagnostic paradigm for Major Depressive Disorder.

Authors:  Syeda Fabeha Husain; Rongjun Yu; Tong-Boon Tang; Wilson W Tam; Bach Tran; Travis T Quek; Shi-Hui Hwang; Cheryl W Chang; Cyrus S Ho; Roger C Ho
Journal:  Sci Rep       Date:  2020-06-16       Impact factor: 4.379

10.  Item-based analysis of the effects of duloxetine in depression: a patient-level post hoc study.

Authors:  Alexander Lisinski; Fredrik Hieronymus; Jakob Näslund; Staffan Nilsson; Elias Eriksson
Journal:  Neuropsychopharmacology       Date:  2019-09-14       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.